$IMRX
Immuneering Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
IMRX chart
What traders are saying about $IMRX
Latest postsImmuneering Corp news
- symbol__ Stock Quote Price and Forecast
CNN ·
- Immuneering Corporation (IMRX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Immuneering Appoints Grant C. Bogle to Board of Directors
TipRanks ·
- Immuneering appoints Grant C. Bogle to its board
TradingView ·
- Immuneering at guggenheim healthcare conference: pancreatic data in focus By Investing.com
Investing.com Canada ·
- Immuneering Appoints Former TESARO Executive Grant Bogle to Board of Directors
citybiz ·
- Immuneering adds former Tesaro CCO Grant Bogle to its board
StreetInsider ·
- Immuneering Appoints Accomplished Commercial Leader Grant Bogle to Board of Directors
Yahoo Finance ·
- Immuneering Corporation (IMRX) stock price, news, quote and history
Yahoo Finance UK ·
- Immuneering Corporation (IMRX) Seasonal Returns Chart
Yahoo! Finance Canada ·
- Immuneering Stock Price Forecast. Should You Buy IMRX?
StockInvest.us ·
- Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026
Yahoo Finance ·
Immuneering Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $0 | $316,952 |
| Net income | -$56.0M | -$61.0M | -$53.5M | -$50.5M |
| Diluted EPS | $-1.27 | $-2.04 | $-1.88 | $-1.91 |
| Total assets (year end) | $232.0M | $52.7M | $102.6M | $122.4M |
| Cash and equivalents (year end) | $128.6M | $36.1M | $59.4M | $72.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immuneering Corp
- Ticker
- IMRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1790340
Frequently asked questions
What exchange is Immuneering Corp listed on?
Immuneering Corp trades on the Nasdaq under the ticker symbol IMRX.
What industry is Immuneering Corp in?
Immuneering Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Immuneering Corp headquartered?
Immuneering Corp's business address on file with the SEC is in Cambridge, MA.
When does Immuneering Corp's fiscal year end?
Immuneering Corp's fiscal year ends on December 31.
How much revenue did Immuneering Corp report?
Immuneering Corp reported $0 in revenue for calendar year 2023, according to its SEC filings.